Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide vs Metformin vs Gliclazide in T2DM with NAFLD
NCT03068065Phase 4Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- May 2014
- Primary completion
- Nov 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), sponsored by Nanjing Drum-Tower Hospital. Started May 2014; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT03068065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03068065.